Results 1 -
10
of
31
for
mycosis fungoides OR "lymphoma," "T-cell" OR erythroderma
- Mechlorethamine gel is used to treat early stage mycosis fungoides-type cutaneous T-cell lymphoma (CTCL; a cancer of the immune system ...
- General Information about Mycosis Fungoides (Including Sézary Syndrome) (National Cancer Institute)Mycosis fungoides (including Sézary Syndrome) treatment options include photodynamic therapy, radiation therapy, chemotherapy, immunotherapy, and targeted ...
- Stages of Mycosis Fungoides (Including Sézary Syndrome) (National Cancer Institute)Mycosis fungoides (including Sézary Syndrome) treatment options include photodynamic therapy, radiation therapy, chemotherapy, immunotherapy, and targeted ...
- Treatment of Recurrent Mycosis Fungoides (Including Sézary Syndrome) (National Cancer Institute)Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Mycosis fungoides (including Sézary Syndrome) treatment ...
- Treatment of Stage I and Stage II Mycosis Fungoides (National Cancer Institute)Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Mycosis fungoides (including Sézary Syndrome) treatment ...
- Treatment Option Overview for Mycosis Fungoides (Including Sézary Syndrome) (National Cancer Institute)Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Mycosis fungoides (including Sézary Syndrome) treatment ...
- Treatment of Stage III and Stage IV Mycosis Fungoides (Including Sézary Syndrome) (National Cancer Institute)Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Mycosis fungoides (including Sézary Syndrome) treatment ...
- ... RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical ...
- ... RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical ...
- Mogamulizumab-kpkc injection is used to treat mycosis fungoides and Sézary syndrome, two types of cutaneous T-cell lymphoma ([CTCL], a group of cancers of the immune system that first appear as skin rashes), in adults whose disease has not improved, ...